Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × lenvatinib × Sarcoma × Clear all

Phase

Status

Completed 4 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Gynecologic 1 Genitourinary 1 Breast 1

Conditions

Sarcoma, Kaposi 1

Interventions

Cyclophosphamide 9 Radiotherapy 7 pazopanib 5 Temozolomide 5 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Vincristine 4 Gemcitabine 4 Etoposide 4 Doxorubicin 4 Docetaxel 4 Carboplatin 4 Biopsy 4 pembrolizumab 3 Taxes 3 Specimen Handling 3 Radiation 3 Paclitaxel 3 Nivolumab 3 Irinotecan 3 Drug Therapy 3 niraparib 2 liposomal doxorubicin 2 fludarabine phosphate 2 fludarabine 2 brigimadlin 2 Trastuzumab 2 Trabectedin 2 Surgical Procedures, Operative 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05846724 2026-01-22

PULSAR

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Phase 2 Withdrawn

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡